Charles River Laboratories secured a contract to produce FibroBiologics' CYWC628 product as a Contract Development and Manufacturing Organization (CDMO).

1 report, 1 independent Updated Aug 5

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Charles River Laboratories

Keep exploring

Part of

FibroBiologics, Inc., based in Houston, is scheduled to present at a conference in New York City. All 1 developments

The entities involved

Charles River Laboratories
major US biomedical company
- Agilent Technologies and Charles River Laboratories are both companies operating in the life sciences sector.Sat 11:57
- Apollo is the digital client engagement platform for Charles River Laboratories, and Mark Mintz serves as CIO and head of global shared services.Sat 11:57

Coverage

Newest first; wire copies grouped

Aug 5Zacks Small Cap ResearchFBLG: Closes Third Tranche of $5M… By David Bautz, PhD NASDAQ:FBLG READ THE FULL FBLG RESEARCH REPORT Business Update Phase 1/2 Trial in Diabetic Foot Ulcers to Initiate in 1Q26 FibroBiologics, Inc.